Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle T Amber

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
Clinical, Cosmetic and Investigational Dermatology|March 19, 2019
Treatment-resistant prurigo nodularis: challenges and solutionsEric H Kowalski, Diana Kneiber, Manuel Valdebran, et al.
Ocular Immunology and Inflammation|August 28, 2025
Development of Superficial Thrombophlebitis and Subsequent Central Retinal Vein Occlusion Occurring in a Patient Receiving IVIg for Ocular PemphigoidKevin Truong-Balderas, Maria Mihailescu, Grace Tu, et al.
Frontiers in Immunology|March 3, 2023
Editorial: Autoimmune pre-diseaseJennifer E Hundt, Markus H Hoffmann, Kyle T Amber, et al.
Experimental Dermatology|September 16, 2018
Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil-derived neurotoxin on human keratinocytesKyle T Amber, Alex Chernyavsky, Arianna F Agnoletti, et al.
Experimental Dermatology|January 18, 2014
Autoreactive T cells in the immune pathogenesis of pemphigus vulgarisKyle T Amber, Patrick Staropoli, Michael I Shiman, et al.
Annals of Gastroenterology|July 3, 2023
Cutaneous Crohn's disease after proctocolectomy for medically refractory colonic Crohn's disease: a case series and review of the literatureSandra Naffouj, Gabriel E Marrero-Rivera, Johan Nordenstam, et al.
Frontiers in Medicine|April 20, 2019
Editorial: Skin Blistering DiseasesCristina Has, Kyle T Amber, Dedee F Murrell, et al.
Journal of the American Academy of Dermatology|November 18, 2017
Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single centerKeshavamurthy Vinay, Simone Cazzaniga, Kyle T Amber, et al.
The Journal of Biological Chemistry|January 30, 2019
Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgarisAlex Chernyavsky, Kyle T Amber, Arianna F Agnoletti, et al.
Journal of the American Academy of Dermatology|December 9, 2019
IgA pemphigus: A systematic reviewKhalaf Kridin, Payal M Patel, Virginia A Jones, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Clinical, Cosmetic and Investigational Dermatology|March 19, 2019
Treatment-resistant prurigo nodularis: challenges and solutionsEric H Kowalski, Diana Kneiber, Manuel Valdebran, et al.
Ocular Immunology and Inflammation|August 28, 2025
Development of Superficial Thrombophlebitis and Subsequent Central Retinal Vein Occlusion Occurring in a Patient Receiving IVIg for Ocular PemphigoidKevin Truong-Balderas, Maria Mihailescu, Grace Tu, et al.
Frontiers in Immunology|March 3, 2023
Editorial: Autoimmune pre-diseaseJennifer E Hundt, Markus H Hoffmann, Kyle T Amber, et al.
Experimental Dermatology|September 16, 2018
Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil-derived neurotoxin on human keratinocytesKyle T Amber, Alex Chernyavsky, Arianna F Agnoletti, et al.
Experimental Dermatology|January 18, 2014
Autoreactive T cells in the immune pathogenesis of pemphigus vulgarisKyle T Amber, Patrick Staropoli, Michael I Shiman, et al.
Annals of Gastroenterology|July 3, 2023
Cutaneous Crohn's disease after proctocolectomy for medically refractory colonic Crohn's disease: a case series and review of the literatureSandra Naffouj, Gabriel E Marrero-Rivera, Johan Nordenstam, et al.
Frontiers in Medicine|April 20, 2019
Editorial: Skin Blistering DiseasesCristina Has, Kyle T Amber, Dedee F Murrell, et al.
Journal of the American Academy of Dermatology|November 18, 2017
Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single centerKeshavamurthy Vinay, Simone Cazzaniga, Kyle T Amber, et al.
The Journal of Biological Chemistry|January 30, 2019
Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgarisAlex Chernyavsky, Kyle T Amber, Arianna F Agnoletti, et al.
Journal of the American Academy of Dermatology|December 9, 2019
IgA pemphigus: A systematic reviewKhalaf Kridin, Payal M Patel, Virginia A Jones, et al.
Pageof 15